Details of the Drug Reposition

General Information of This Drug (ID: DMX9EA0)

Drug Name	TAK-058 DMX9EA0

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Schizophrenia	DISSRV2N	6A20	Phase 1	[1]
XY disorder of sex development due to androgen resistance	DIS14LM8	LD2A.4	Phase 1	[2]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT02389881) Safety, Tolerability, and Pharmacokinetics of Multiple-Dose TAK-058 in Healthy Participants. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)